Neuroendoscopy-assisted drainage versus burr hole drainage for chronic subdural hematoma (URANUS): study protocol for a multicenter randomized controlled trial.
Liang Wu, Yu Yan, Yu Deng...
https://pubmed.ncbi.nlm.nih.gov/41845395/Actively Recruiting
Led by Beijing Tiantan Hospital · Updated on 2026-02-09
770
Participants Needed
24
Research Sites
21 weeks
Total Duration
Chronic subdural hematoma CSDH is a common neurosurgical condition where fluid collects between layers of the brains protective membranes, causing brain compression and neurological problems. This condition can be life-threatening if severe, and current treatments lack a clear standard due to uncertain long-term outcomes. Researchers are conducting a multicenter randomized trial to compare two surgical methods to find the best treatment approach for CSDH. The study compares neuroendoscopy-assisted hematoma drainage to conventional burr-hole drainage. Neuroendoscopy allows surgeons to see and remove the hematoma more thoroughly using a small bone flap and a visualized neuroendoscope, aiming to reduce residual hematoma and recurrence. Burr-hole drainage uses a single hole to irrigate and drain the hematoma. Both procedures involve continuous drainage for up to 48 hours post-surgery or until drainage stops naturally. Participants will be adults aged 18 to 90 with diagnosed CSDH requiring surgery. Researchers will assess recurrence rates, mortality, neurological function scales, quality of life, complications, drainage time, and hospital stay length over three months after surgery. Follow-up visits occur at Day 0, Day 2, Month 1, and Month 3 to monitor outcomes and safety. The total study duration per participant is three months post-operation.
CONDITIONS
Neuroendoscopy-assisted Drainage Versus Burr Hole Drainage for Chronic Subdural Hematoma
L
Liang Wu, MD
Y
Yu Yan, MB
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Beijing Tiantan Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit
Duration - Up to 2 days
Participants undergo either neuroendoscopy-assisted hematoma drainage or burr hole hematoma drainage surgery. Postoperatively, continuous subdural drainage is maintained until it ceases naturally or the drainage tube is removed within 48 hours.
1 surgery visit and daily postoperative monitoring until drainage removal
Duration - 3 months
Participants are followed for recovery, monitoring recurrence, complications, and neurological function for 3 months after surgery.
Visits on Day 2, Month 1, and Month 3 after operation
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Liang Wu, Yu Yan, Yu Deng...
https://pubmed.ncbi.nlm.nih.gov/41845395/Yu Zhang, Shiping Chen, Yangchun Xiao...
https://pubmed.ncbi.nlm.nih.gov/28578110/T Santarius, P J Hutchinson
https://pubmed.ncbi.nlm.nih.gov/15702829/J Shapey, L J Glancz, P M Brennan
https://pubmed.ncbi.nlm.nih.gov/27213133/Jing Lu, Dongwei Shen, Fangjin Hu...
https://pubmed.ncbi.nlm.nih.gov/26067723/K Mori, M Maeda
https://pubmed.ncbi.nlm.nih.gov/11561347/Henri-Arthur Leroy, Rabih Aboukaïs, Nicolas Reyns...
https://pubmed.ncbi.nlm.nih.gov/26260114/Weiming Liu, Nicolaas A Bakker, Rob J M Groen
https://pubmed.ncbi.nlm.nih.gov/24995782/Satoshi Kurabe, Tsunenori Ozawa, Toru Watanabe...
https://pubmed.ncbi.nlm.nih.gov/20336332/R G Robinson
https://pubmed.ncbi.nlm.nih.gov/6737050/Beijing Tiantan Hospital
Lead Sponsor